Jorda; Radek Patent Filings

Patent	Date
5-alkylthio-7-[(4-arylbenzyl)amino]-1(2)H-pyrazolo[4,3-d]pyrimidines for treatment of lymphoma Grant 11,186,583 - Havlicek , et al. November 30, 2	2021-11-30
2,6-disubstituted-9-cyclopentyl-9H-purines, use thereof as medicaments, and pharmaceutical compositions Grant 11,028,087 - Gucky , et al. June 8, 2	2021-06-08
5-alkylthio-7-[(4-arylbenzyl)amino]-1(2)h-pyrazolo[4,3-d]pyrimidines For Treatment Of Lymphoma App 20200361943 - HAVLICEK; Libor ; et al.	2020-11-19
2,6-disubstituted-9-cyclopentyl-9h-purines, Use Thereof As Medicaments, And Pharmaceutical Compositions App 20200087306 - GUCKY; TOMAS ; et al.	2020-03-19
5-substituted 7- [4-(2-pyridyl)phenylmethylamino] -3-isopropylpyrazolo4,3-D]pyrimidine derivatives, use thereof as medicaments, and pharmaceutical compositions Grant 9,957,273 - Havlicek , et al. May 1, 2	2018-05-01
5-substituted 7-[4-(2-pyridyl)phenylmethylamino]-3-isopropylpyrazolo4,3-d]pyrimidine Derivatives, Use Thereof As Medicaments, And Pharmaceutical Compositions App 20180072736 - HAVLICEK; Libor ; et al.	2018-03-15
2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine Derivatives, Use Thereof As Medicaments, And Pharmaceutical Compositions App 20150368248 - GUCKY; Tomas ; et al.	2015-12-24
Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives Grant 8,492,391 - Zatloukal , et al. July 23, 2	2013-07-23
Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives App 20120070512 - Zatloukal; Marek ; et al.	2012-03-22

Patent

Date

5-alkylthio-7-[(4-arylbenzyl)amino]-1(2)H-pyrazolo[4,3-d]pyrimidines for treatment of lymphoma
Grant 11,186,583 - Havlicek , et al. November 30, 2

2021-11-30

2,6-disubstituted-9-cyclopentyl-9H-purines, use thereof as medicaments, and pharmaceutical compositions
Grant 11,028,087 - Gucky , et al. June 8, 2

2021-06-08

5-alkylthio-7-[(4-arylbenzyl)amino]-1(2)h-pyrazolo[4,3-d]pyrimidines For Treatment Of Lymphoma
App 20200361943 - HAVLICEK; Libor ; et al.

2020-11-19

2,6-disubstituted-9-cyclopentyl-9h-purines, Use Thereof As Medicaments, And Pharmaceutical Compositions
App 20200087306 - GUCKY; TOMAS ; et al.

2020-03-19

5-substituted 7- [4-(2-pyridyl)phenylmethylamino] -3-isopropylpyrazolo4,3-D]pyrimidine derivatives, use thereof as medicaments, and pharmaceutical compositions
Grant 9,957,273 - Havlicek , et al. May 1, 2

2018-05-01

5-substituted 7-[4-(2-pyridyl)phenylmethylamino]-3-isopropylpyrazolo4,3-d]pyrimidine Derivatives, Use Thereof As Medicaments, And Pharmaceutical Compositions
App 20180072736 - HAVLICEK; Libor ; et al.

2018-03-15

2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine Derivatives, Use Thereof As Medicaments, And Pharmaceutical Compositions
App 20150368248 - GUCKY; Tomas ; et al.

2015-12-24

Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives
Grant 8,492,391 - Zatloukal , et al. July 23, 2

2013-07-23

Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives
App 20120070512 - Zatloukal; Marek ; et al.

2012-03-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

Jorda; Radek

Patent Applications and Registrations